Alzheimer disease therapeutics: Perspectives from the developing world

Saad Shafqat

Research output: Contribution to journalShort surveypeer-review

20 Citations (Scopus)


Although a majority of dementia patients live in middle-income and low-income countries, dementia represents an under-recognized public health burden in the developing world. Culturally and socially, it tends to be trivialized as an inevitable consequence of aging. Economic constraints are paramount, precluding the availability of institutionalized elder care and a state-sponsored health care system. Evidence-based practice for the management of dementia is also hampered by lack of a clear-cut expert consensus on the efficacy of anti-dementia drugs. Public health education, substantial health infrastructure development, and therapeutic advances are necessary for the developing world's looming dementia crisis to be adequately tackled.

Original languageEnglish
Pages (from-to)285-287
Number of pages3
JournalJournal of Alzheimer's Disease
Issue number2
Publication statusPublished - 2008


  • Constraints
  • Cultural
  • Economic
  • Social


Dive into the research topics of 'Alzheimer disease therapeutics: Perspectives from the developing world'. Together they form a unique fingerprint.

Cite this